446286-45-9 Usage
Uses
Used in Organic Synthesis:
2-ACETYLAMINO-5-(TRIBUTYLSTANNYL)THIAZOLE is used as a reagent for the functionalization of thiazole-containing compounds. Its tributylstannyl group acts as a leaving group in organic reactions, facilitating the introduction of other functional groups.
Used in Pharmaceutical Preparation:
In the pharmaceutical industry, 2-ACETYLAMINO-5-(TRIBUTYLSTANNYL)THIAZOLE is used as a key intermediate in the synthesis of various drugs. Its unique structure and reactivity contribute to the development of new pharmaceuticals with improved therapeutic properties.
Used in Agrochemical Development:
2-ACETYLAMINO-5-(TRIBUTYLSTANNYL)THIAZOLE also finds application in the agrochemical sector, where it is utilized in the preparation of pesticides and other agrochemicals. Its ability to modify biologically active molecules aids in the creation of more effective and targeted agrochemical products.
Used in Materials Chemistry:
In the field of materials chemistry, 2-ACETYLAMINO-5-(TRIBUTYLSTANNYL)THIAZOLE is employed for the development of new materials with specific properties. Its versatile reactivity allows for the synthesis of materials with tailored characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 446286-45-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,2,8 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 446286-45:
(8*4)+(7*4)+(6*6)+(5*2)+(4*8)+(3*6)+(2*4)+(1*5)=169
169 % 10 = 9
So 446286-45-9 is a valid CAS Registry Number.
446286-45-9Relevant academic research and scientific papers
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 111, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
